Texas Tech University Health Sciences Center at Lubbock Pediatric Hematology/Oncology

Topics

• Retinoids in leukemia and cellular processes 13
• Neuroblastoma Research and Treatments 12
• Sphingolipid Metabolism and Signaling 8
• Acute Lymphoblastic Leukemia research 2
• Autoimmune and Inflammatory Disorders Research 2
• Bone Tumor Diagnosis and Treatments 2
• Molecular Biology Techniques and Applications 2
• Protein Tyrosine Phosphatases 2
• 3D Printing in Biomedical Research 1
• Acute Myeloid Leukemia Research 1
• Aldose Reductase and Taurine 1
• Bartonella species infections research 1

Most cited

1. A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumors.

   Cancer chemotherapy and pharmacology · 2021 · 18 citations · Barry Maurer

2. Coumarin-Based Aldo-Keto Reductase Family 1C (AKR1C) 2 and 3 Inhibitors.

   ChemMedChem · 2024 · 4 citations · Barry Maurer

3. DNA-PKcs as an upstream mediator of OCT4-induced MYC activation in small cell lung cancer.

   Biochimica et biophysica acta. Gene regulatory mechanisms · 2023 · 7 citations · Barry Maurer

4. Phase I trial of intravenous fenretinide (4-HPR) plus safingol in advanced malignancies.

   Cancer chemotherapy and pharmacology · 2023 · 4 citations · Barry Maurer

5. Red blood cell distribution width as a potential inflammatory marker in pediatric osteomyelitis.

   Proceedings (Baylor University. Medical Center) · 2023 · 2 citations · Mohamad Al-Rahawan

6. Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531.

   Pediatric blood & cancer · 2024 · 0 citations · Erin Barr